Since 1864, the British Pharmacopoeia (BP) has been providing authoritative official standards for pharmaceutical substances and medicinal products. It makes an important contribution to the role of the Medicines and Healthcare products Regulatory Agency in protecting public health by setting publicly available standards for the quality of medicines.
The British Pharmacopoeia maintains close ties with the work of the European Pharmacopoeia and continues to play a significant role in the standard-setting process in Europe, participating in the activities of the European Directorate for the Quality of Medicines and Healthcare, and influencing the decisions of the European Pharmacopoeia Commission through the United Kingdom Delegation. The texts and monographs of the European Pharmacopoeia form an integral part of the BP.
Annually updated, the British Pharmacopoeia is the only comprehensive collection of standards for UK medicinal substances. It is essential for all individuals and organisations involved in pharmaceutical research, development, manufacture, quality control and analysis.
BPCRS are supplied solely for use in the tests and assays of the British Pharmacopoeia or British Pharmacopoeia (Veterinary) in which a BPCRS is required. They are issued only for chemical analysis and may not be suitable for any other purposes. They are not intended for administration to humans or animals. BPCRS are supplied in unit packs containing sufficient material to carry out the prescribed procedures.